IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients. Nishio M, Saito H, Goto K, Watanabe S, et al. Cancer Sci 2021;112:1534-1544.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nishio M, Saito H, Goto K, Watanabe S, et al. IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients. Cancer Sci 2021;112:1534-1544.
PMID: 33462883